• 6426 Citations
  • 34 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 6426 Citations
  • 34 h-Index
  • 119 Article
  • 6 Review article
  • 5 Letter
  • 1 Comment/debate
Filter
Article
Article

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis

Nicolini, F. E., Masszi, T., Shen, Z., Gallagher, N. J., Jootar, S., Powell, B. L., Dorlhiac-Llacer, P. E., Zheng, M., Szczudlo, T. & Turkina, A., máj. 1 2012, In : Leukemia and Lymphoma. 53, 5, p. 907-914 8 p.

Research output: Article

16 Citations (Scopus)

Familial multiple myeloma. Two more families

Várkonyi, J., Farkas, P., Tamáska, J., Masszi, T., Gopcsa, L., Padányi, Á. & Rajczy, K., dec. 1 2009, In : Central European Journal of Medicine. 4, 4, p. 501-505 5 p.

Research output: Article

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Moskowitz, C. H., Walewski, J., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Viviani, S., Bachanova, V., Sureda, A., McClendon, T., Lee, C., Lisano, J. & Sweetenham, J., dec. 20 2018, In : Blood. 132, 25, p. 2639-2642 4 p.

Research output: Article

36 Citations (Scopus)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the European ENEST1st study

Hochhaus, A., Rosti, G., Cross, N. C. P., Steegmann, J. L., Le Coutre, P., Ossenkoppele, G., Petrov, L., Masszi, T., Hellmann, A., Griskevicius, L., Wiktor-Jedrzejczak, W., Rea, D., Coriu, D., Brümmendorf, T. H., Porkka, K., Saglio, G., Gastl, G., Müller, M. C., Schuld, P., Di Matteo, P. & 5 others, Pellegrino, A., Dezzani, L., Mahon, F. X., Baccarani, M. & Giles, F. J., jan. 1 2016, In : Leukemia. 30, 1, p. 57-64 8 p.

Research output: Article

65 Citations (Scopus)

Gram-negatív bacteriaemia neutropeniás hematológiai betegekben. Tapasztalatok fluorokinolonprofilaxis alkalmazása kapcsán

Sinkó, J., Cser, V., Konkoly Thege, M. & Masszi, T., júl. 1 2011, In : Orvosi hetilap. 152, 27, p. 1063-1067 5 p.

Research output: Article

3 Citations (Scopus)

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Basic-Kinda, S., Mayer, J., Masszi, T., Giebel, S., Labar, B. & Wiktor-Jedrzejczak, W., jún. 2011, In : European journal of haematology. 86, 6, p. 488-495 8 p.

Research output: Article

31 Citations (Scopus)

Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: Development, recent activity and role of the EBMT/ ESH Outreach Programme

Wachowiak, J., Labopin, M., Miano, M., Chybicka, A., Stary, J., Sterba, J., Masszi, T., Labar, B., Maschan, A., Kowalczyk, J. R., Lange, A., Holowiecki, J., Kalman, N., Afanassiev, B. V. & Dini, G., jún. 1 2008, In : Bone Marrow Transplantation. 41, SUPPL. 2, p. S112-S117

Research output: Article

14 Citations (Scopus)

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T. & Kim, D. W., ápr. 1 2012, In : Leukemia Research. 36, 4, p. 438-442 5 p.

Research output: Article

29 Citations (Scopus)

Health-related quality-of-life results from the open-label, randomized, phase III ASPIRE trial evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patientswith relapsed multiple myeloma

Stewart, A. K., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Niesvizky, R., Jakubowiak, A. J., San-Miguel, J. F., Ludwig, H., Buchanan, J., Cocks, K., Yang, X., Xing, B., Zojwalla, N., Tonda, M., Moreau, P. & Palumbo, A., nov. 10 2016, In : Journal of Clinical Oncology. 34, 32, p. 3921-3930 10 p.

Research output: Article

38 Citations (Scopus)

HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease

Andrikovics, H., Meggyesi, N., Szilvasi, A., Tamaska, J., Halm, G., Lueff, S., Nahajevszky, S., Egyed, M., Varkonyi, J., Mikala, G., Sipos, A., Kalasz, L., Masszi, T. & Tordai, A., márc. 2009, In : Cancer Epidemiology Biomarkers and Prevention. 18, 3, p. 929-934 6 p.

Research output: Article

7 Citations (Scopus)

High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party

Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A. & Dreger, P., jan. 2018, In : American Journal of Hematology. 93, 1, p. 40-46 7 p.

Research output: Article

6 Citations (Scopus)
65 Citations (Scopus)

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Mayer, J., Masszi, T., Labar, B. & Wiktor-Jedrzejczak, W., júl. 2011, In : American Journal of Hematology. 86, 7, p. 550-553 4 p.

Research output: Article

20 Citations (Scopus)

Identification of the best-suited donor for generating virus-specific T cells

Tasnády, S., Karászi, É., Szederjesi, A., Bihari, G., Juhász, Z., Hardi, A., Kriván, G., Kállay, K., Reményi, P., Sinkó, J., Mikala, G., Réti, M. & Masszi, T., jan. 1 2020, In : Vox sanguinis. 115, 1, p. 18-26 9 p.

Research output: Article

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT

Gagelmann, N., Eikema, D. J., Iacobelli, S., Koster, L., Nahi, H., Stoppa, A. M., Masszi, T., Caillot, D., Lenhoff, S., Udvardy, M., Crawley, C., Arcese, W., Mariette, C., Hunter, A., Leleu, X., Schipperus, M., Delforge, M., Pioltelli, P., Snowden, J. A., Itälä-Remes, M. & 4 others, Musso, M., van Biezen, A., Garderet, L. & Kröger, N., ápr. 30 2018, In : Haematologica. 103, 5, p. 890-897 8 p.

Research output: Article

13 Citations (Scopus)

Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia

on behalf of the Chronic Malignancies Working Party of the European Society for Blood Marrow Transplantation, máj. 2019, In : British Journal of Haematology. 185, 4, p. 725-732 8 p.

Research output: Article

2 Citations (Scopus)

Impact of prior therapy on the efficacy and safety of oral ixazomiblenalidomide-dexamethasone vs. Placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1

Mateos, M. V., Masszi, T., Grzasko, N., Hansson, M., Sandhu, I., Pour, L., Viterbo, L., Jackson, S. R., Stoppa, A. M., Gimsing, P., Hamadani, M., Borsaru, G., Berg, D., Lin, J., Di Bacco, A., Van De Velde, H., Richardson, P. G. & Moreau, P., szept. 30 2017, In : Haematologica. 102, 10, p. 1767-1775 9 p.

Research output: Article

25 Citations (Scopus)

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: An autopsy-driven survey

Sinkó, J., Csomor, J., Nikolova, R., Lueff, S., Kriván, G., Reményi, P., Bátai, Á. & Masszi, T., ápr. 1 2008, In : Transplant Infectious Disease. 10, 2, p. 106-109 4 p.

Research output: Article

44 Citations (Scopus)

Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Kövy, P., Meggyesi, N., Varga, L., Balassa, K., Bors, A., Gopcsa, L., Paksi, M., Bátai, Á., Vad, E., Sinkó, J., Tordai, A., Masszi, T., Reményi, P. & Andrikovics, H., jan. 1 2020, In : Bone Marrow Transplantation. 55, 1, p. 215-223 9 p.

Research output: Article

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients

Avet-Loiseau, H., Bahlis, N. J., Chng, W. J., Masszi, T., Viterbo, L., Pour, L., Ganly, P., Palumbo, A., Cavo, M., Langer, C., Pluta, A., Nagler, A., Kumar, S., Ben-Yehuda, D., Rajkumar, S. V., San-Miguel, J., Berg, D., Lin, J., Van De Velde, H., Esseltine, D. L. & 3 others, di Bacco, A., Moreau, P. & Richardson, P. G., dec. 14 2017, In : Blood. 130, 24, p. 2610-2618 9 p.

Research output: Article

39 Citations (Scopus)

Komplex molekuláris genetikai vizsgálati algoritmus myeloproliferativ neoplasiák diagnosztikájában

Krhling, T., Balassa, K., Meggyesi, N., Bors, A., Csomor, J., Bátai, Á., Halm, G., Egyed, M., Fekete, S., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., dec. 1 2014, In : Orvosi hetilap. 155, 52, p. 2074-2081 8 p.

Research output: Article

4 Citations (Scopus)

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

Tichelli, A., Passweg, J., Wójcik, D., Rovó, A., Harousseau, J. L., Masszi, T., Zander, A., Békássy, A., Crawley, C., Arat, M., Sica, S., Lutz, P. & Socié, G., aug. 2008, In : Haematologica. 93, 8, p. 1203-1210 8 p.

Research output: Article

110 Citations (Scopus)

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia

Mátrai, Z., Andrikovics, H., Szilvási, A., Bors, A., Kozma, A., Ádám, E., Halm, G., Karászi, É., Tordai, A. & Masszi, T., okt. 18 2016, (Accepted/In press) In : Pathology and Oncology Research. p. 1-7 7 p.

Research output: Article

4 Citations (Scopus)

Lymphocyte subset reconstitution after allogeneic bone marrow transplantation using radiation-free conditioning regimen for patients with chronic granulocytic leukemia

Milosevits, J., Dénes, R., Poros, A., Reményi, P., Bátai, Á., Barta, A., Masszi, T., Lengyel, L., Jakab, K., Földi, J., Petrányi, G., Kelemen, E. & Pálóczi, K., júl. 1995, In : International Journal of Hematology. 62, 1, p. 27-33 7 p.

Research output: Article

6 Citations (Scopus)

Lymphoid aggregates may contribute to the migration and epithelial commitment of Bone marrow-derived cells in colonic mucosa

Valcz, G., Krenács, T., Sipos, F., Patai, Á. V., Wichmann, B., Leiszter, K., Tóth, K., Balogh, Z., Csizmadia, A., Hagymási, K., Masszi, T., Molnár, B. & Tulassay, Z., szept. 1 2011, In : Journal of Clinical Pathology. 64, 9, p. 771-775 5 p.

Research output: Article

8 Citations (Scopus)

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

Kumar, S., Moreau, P., Hari, P., Mateos, M. V., Ludwig, H., Shustik, C., Masszi, T., Spencer, A., Hájek, R., Romeril, K., Avivi, I., Liberati, A. M., Minnema, M. C., Einsele, H., Lonial, S., Berg, D., Lin, J., Gupta, N., Esseltine, D. L. & Richardson, P. G., aug. 2017, In : British Journal of Haematology. 178, 4, p. 571-582 12 p.

Research output: Article

30 Citations (Scopus)

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Koszarska, M., Meggyesi, N., Bors, A., Batai, A., Csacsovszki, O., Lehoczky, E., Adam, E., Kozma, A., Lovas, N., Sipos, A., Krahling, T., Dolgos, J., Remenyi, P., Fekete, S., Masszi, T., Tordai, A. & Andrikovics, H., júl. 2014, In : Leukemia and Lymphoma. 55, 7, p. 1510-1517 8 p.

Research output: Article

5 Citations (Scopus)

Mennyit vár ma Magyarországon egy myelomás beteg a diagnózisig?

Varga, G., Mikala, G., Andrikovics, H. & Masszi, T., szept. 1 2014, In : Orvosi hetilap. 155, 39, p. 1538-1543 6 p.

Research output: Article

2 Citations (Scopus)

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma

Varga, G., Mikala, G., Andrikovics, H., Koszarska, M., Balassa, K., Ádám, E., Kozma, A., Tordai, A. & Masszi, T., márc. 1 2015, In : British Journal of Haematology. 168, 5, p. 679-688 10 p.

Research output: Article

8 Citations (Scopus)

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors

Khoury, H. J., Cortes, J., Baccarani, M., Wetzler, M., Masszi, T., Digumarti, R., Craig, A., Benichou, A. C. & Akard, L., jan. 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 120-127 8 p.

Research output: Article

15 Citations (Scopus)

Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma

TOURMALINE-MM1 Study Group, ápr. 28 2016, In : New England Journal of Medicine. 374, 17, p. 1621-1634 14 p.

Research output: Article

480 Citations (Scopus)

Ossejtek alkalmazása a cardiovascularis betegségek kezelésében

Vértesaljai, M., Piróth, Z., Fontos, G., Andréka, G., Font, G., Szántho, G., Réti, M., Masszi, T. & Andréka, P., dec. 1 2005, In : Orvosi hetilap. 146, 47, p. 2383-2388 6 p.

Research output: Article

4 Citations (Scopus)

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Giebel, S., Labopin, M., Holowiecki, J., Labar, B., Komarnicki, M., Koza, V., Masszi, T., Mistrik, M., Lange, A., Hellmann, A., Vitek, A., Pretnar, J., Mayer, J., Rzepecki, P., Indrak, K., Wiktor-Jedrzejczak, W., Wojnar, J., Krawczyk-Kulis, M., Kyrcz-Krzemien, S. & Rocha, V., 2009, In : Annals of Hematology. 88, 10, p. 1005-1013 9 p.

Research output: Article

26 Citations (Scopus)

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

Leleu, X., Masszi, T., Bahlis, N. J., Viterbo, L., Baker, B., Gimsing, P., Maisnar, V., Samoilova, O., Rosiñol, L., Langer, C., Song, K., Izumi, T., Cleeland, C., Berg, D., Lin, H. M., Zhu, Y., Skacel, T., Moreau, P. & Richardson, P. G., aug. 2018, In : American Journal of Hematology. 93, 8, p. 985-993 9 p.

Research output: Article

19 Citations (Scopus)

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Reményi, P., Gopcsa, L., Marton, I., Réti, M., Mikala, G., Pető, M., Barta, A., Bátai, Á., Farkas, Z., Borbényi, Z., Csukly, Z., Bodó, I., Fábián, J., Király, Á., Lengyel, L., Piukovics, K., Torbágyi, É. & Masszi, T., ápr. 1 2014, In : Advances in Therapy. 31, 4, p. 451-460 10 p.

Research output: Article

19 Citations (Scopus)

Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis

Csire, M., Mikala, G., Jákó, J., Masszi, T., Jánosi, J., Dolgos, J., Füle, T., Tordai, A., Berencsi, G. & Vályi-Nagy, I., jan. 1 2007, In : Pathology and Oncology Research. 13, 2, p. 157-160 4 p.

Research output: Article

16 Citations (Scopus)

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

Stone, R. M., Mazzola, E., Neuberg, D., Allen, S. L., Pigneux, A., Stuart, R. K., Wetzler, M., Rizzieri, D., Erba, H. P., Damon, L., Jang, J. H., Tallman, M. S., Warzocha, K., Masszi, T., Sekeres, M. A., Egyed, M., Horst, H. A., Selleslag, D., Solomon, S. R., Venugopal, P. & 2 others, Lundberg, A. S. & Powell, B., márc. 20 2015, In : Journal of Clinical Oncology. 33, 11, p. 1252-1257 6 p.

Research output: Article

38 Citations (Scopus)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: Safety and efficacy data in a series of 21 patients from Europe and the USA

Douglas, K. W., Parker, A. N., Hayden, P. J., Rahemtulla, A., D'Addio, A., Lemoli, R. M., Rao, K., Maris, M., Pagliuca, A., Uberti, J., Scheid, C., Noppeney, R., Cook, G., Bokhari, S. W., Worel, N., Mikala, G., Masszi, T., Taylor, R. & Treisman, J., jan. 1 2012, In : Bone Marrow Transplantation. 47, 1, p. 18-23 6 p.

Research output: Article

15 Citations (Scopus)

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: It's not too late

Basak, G. W., Mikala, G., Koristek, Z., Jaksic, O., Basic-Kinda, S., Cegledi, A., Reti, M., Masszi, T., Mayer, J., Giebel, S., Hbel, K., Labar, B. & Wiktor-Jedrzejczak, W., szept. 2011, In : Leukemia and Lymphoma. 52, 9, p. 1711-1719 9 p.

Research output: Article

21 Citations (Scopus)
33 Citations (Scopus)

Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma

Varga, G., Mikala, G., Kiss, K. P., Kosóczki, É., Szabó, E., Meggyesi, N., Balassa, K., Kövy, P., Tegze, B., Szombath, G., Tordai, A., Andrikovics, H., Homolya, L. & Masszi, T., nov. 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 11, p. 734-742 9 p.

Research output: Article

1 Citation (Scopus)

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation

Janicsák, H., Masszi, T., Reményi, P., Ungvari, G. S. & Gazdag, G., aug. 1 2013, In : European journal of haematology. 91, 2, p. 135-140 6 p.

Research output: Article

10 Citations (Scopus)

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

Ramsey, S. D., Nademanee, A., Masszi, T., Holowiecki, J., Abidi, M., Chen, A., Stiff, P., Viviani, S., Sweetenham, J. W., Radford, J., Zhu, Y., Bonthapally, V., Thomas, E., Richhariya, A., Hunder, N. N., Walewski, J. & Moskowitz, C. H., dec. 1 2016, In : British Journal of Haematology. 175, 5, p. 860-867 8 p.

Research output: Article

10 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., ápr. 1 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Article

3 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., jan. 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Article

60 Citations (Scopus)

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Lovas, S., Varga, G., Farkas, P., Masszi, T., Wohner, N., Bereczki, Á., Adamkovich, N., Borbényi, Z., Szomor, Á., Alizadeh, H., Szaleczky, E., Wolf, K., Schneider, T., Plander, M., Szendrei, T., Csacsovszki, O., Csukly, Z., Rajnics, P., Egyed, M., Nagy, Z. & 4 others, Rejtő, L., Illés, Á., Mikala, G. & Váróczy, L., nov. 1 2019, In : International Journal of Hematology. 110, 5, p. 559-565 7 p.

Research output: Article

4 Citations (Scopus)

Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Balassa, K., Krahling, T., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Torbagyi, E., Gopcsa, L., Lengyel, L., Barta, A., Varga, G., Tordai, A., Masszi, T. & Andrikovics, H., júl. 7 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Article

4 Citations (Scopus)
Open Access
37 Citations (Scopus)

Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia

Barta, A., Dénes, R., Masszi, T., Reményi, P., Bátai, Á., Torbágyi, É., Sipos, A., Lengyel, L., Jakab, K., Gyódi, É., Réti, M., Földi, J., Páldi-Haris, P., Avalos, M., Pálóczi, K., Fekete, S., Török, J., Hoffer, I., Jakab, J., Váradi, G. & 2 others, Kelemen, E. & Petrányi, G., júl. 18 2001, In : Acta Haematologica. 105, 2, p. 64-70 7 p.

Research output: Article

13 Citations (Scopus)